Surmodics reported $24.71M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Abbott ABT:US $ 7675M 2124M
Align Technology ALGN:US $ 926.12M 173.25M
Anika Therapeutics ANIK:US $ 90.32M 4.06M
Arrowhead Research ARWR:US $ 86.41M 5.18M
Baxter International BAX:US $ 2294M 657M
Bioscrip BIOS:US $ 145.6M 26.18M
Boston Scientific BSX:US $ 325M 1600M
Cryolife CRY:US $ 51.41M 3.6M
Edap Tms EDAP:US $ 46.5M 0.68M
Edwards Lifesciences EW:US $ 1030.9M 168.1M
Haemonetics HAE:US $ 259.5M 22.62M
Heron Therapeutics HRTX:US $ 56.91M 33.63M
Johnson & Johnson JNJ:US $ 1579M 322M
Merit Medical Systems MMSI:US $ 53.88M 13.88M
Mesa Laboratories MLAB:US $ 49.35M 2.36M
Nektar Therapeutics NKTR:US $ 67.99M 42.78M
Stryker SYK:US $ 1458M 1486M
Surmodics SRDX:US $ 24.71M 1.94M